EdgarLookup

Farwell Wildon

Insider transactions at 1 company

This page shows all SEC Form 4 filings attributed to Farwell Wildon. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.

DYN
Company Title Type Shares Price Value Date
DYN Chief Medical Officer Sale 2,060 $45.01 $92,721 Aug 19, 2024
DYN Chief Medical Officer Sale 1,628 $31.27 $50,908 Jun 11, 2024
DYN Chief Medical Officer Sale 425 $28.59 $12,151 May 16, 2024
DYN Chief Medical Officer Sale 1,585 $25.70 $40,735 Mar 12, 2024
DYN Chief Medical Officer Sale 8,364 $25.80 $215,791 Mar 7, 2024
DYN Chief Medical Officer Sale 407 $25.00 $10,175 Feb 28, 2024
DYN Chief Medical Officer Sale 5,493 $25.07 $137,710 Feb 12, 2024
DYN Chief Medical Officer Sale 100 $25.00 $2,500 Jan 26, 2024
DYN Chief Medical Officer Sale 978 $10.55 $10,318 Dec 11, 2023
DYN Chief Medical Officer Award / Grant 82,512 Nov 15, 2023
DYN Chief Medical Officer Sale 1,707 $10.41 $17,770 Sep 12, 2023
DYN Chief Medical Officer Sale 1,698 $12.43 $21,106 Jun 13, 2023
DYN Chief Medical Officer Sale 7,441 $13.33 $99,189 Mar 14, 2023
DYN Chief Medical Officer Award / Grant 36,000 Dec 12, 2022
DYN Chief Medical Officer Disposition 658 $14.05 $9,245 Sep 15, 2022
DYN Chief Medical Officer Disposition 668 $4.95 $3,307 Jun 14, 2022
DYN Chief Medical Officer Sale 640 $8.73 $5,587 Mar 11, 2022
DYN Chief Medical Officer Sale 5,617 $8.56 $48,082 Mar 2, 2022
DYN Chief Medical Officer Award / Grant 22,307 Dec 10, 2021
DYN Chief Medical Officer Award / Grant 50,000 Mar 2, 2021